Cadherin 5 anticorps (PE-Cy7)

N° du produit ABIN2659098

Cet anticorps Rat Monoclonal détecte spécifiquement Cadherin 5 dans WB, IHC, Neut, ICFC, CyTOF, ELISA (Capture) et ELISPOT (Capture). Il présente une réactivité envers Souris.

Aperçu rapide pour Cadherin 5 anticorps (PE-Cy7) (ABIN2659098)

Antigène: Cadherin 5 (CDH5)

Reactivité: Souris

Hôte: Rat

Clonalité: Monoclonal

Conjugué: Cet anticorp Cadherin 5 est conjugé à/à la PE-Cy7

Application: Western Blotting (WB), Immunohistochemistry (IHC), Neutralization (Neut), Intracellular Flow Cytometry (ICFC), Cytometry by Time of Flight (CyTOF), ELISA (Capture), ELISpot (Capture) (ELISPOT (Capture))

Clone: BV13

Détail du produit anti-Cadherin 5 anticorps (PE-Cy7)

Purification: The antibody was purified by affinity chromatography and conjugated with PE/Cy7 under optimal conditions. The solution is free of unconjugated PE/Cy7 and unconjugated antibody.

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: 0.2 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Protect from prolonged exposure to light. Do not freeze.

Stock: 4 °C

Stockage commentaire: The antibody solution should be stored undiluted between 2°C and 8°C.

Détails sur Cadherin 5

Antigène: Cadherin 5 (CDH5)

Autre désignation: CD144

Sujet: CD144, also known as vascular endothelial-cadherin (VE-cadherin), is a 120 kD member of the type II Cadherin family. It is an endothelial specific hemophilic adhesion molecule involved in endothelial cell survival, migration, contact-dependent growth inhibition, and homophilic adhesion. VE-cadherin is essential for maintaining the integrity of the endothelial barrier in vivo.

Pathways: Cell-Cell Junction Organization, Signaling Events mediated by VEGFR1 and VEGFR2